Researchers Propose a Clinical Trial To Test MMR Vaccine for COVID-19

Administering the MMR (measles, mumps, rubella) vaccine could serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection, say a team of experts in this week’s mBio, a journal of the American Society for Microbiology. Long-time collaborators and spouses Dr. Paul Fidel, Jr., Department Chair, Oral and Craniofacial Biology, and Associate Dean for Research, Louisiana State University Health School of Dentistry and Dr. Mairi Noverr Professor of Microbiology & Immunology at Tulane University School of Medicine in New Orleans co-authored the perspective article based on ideas stemming from research in their labs. Vaccination with MMR in immunocompetent individuals has no contraindications and may be especially effective for health care workers who can easily be exposed to COVID-19, say the researchers.https://www.technologynetworks.com/biopharma/news/researchers-propose-a-clinical-trial-to-test-mmr-vaccine-for-covid-19-336390?utm_campaign=NEWSLETTER_TN_Breaking%20Science%20News&utm_medium=email&_hsmi=89967446&_hsenc=p2ANqtz-_C8UMlCk6j6TeMseFppYPvww2XDf6C52_9ok2ytGS7NAs6AxMuzdVGU5Znm4X6RE6wuULke1QY2Yp-zxIuu5wLJarQUg&utm_content=89967446&utm_source=hs_email